wegovy chills side effect semaglutide Wegovy® Effects & Safety Profile Wegovy® Side Effects & Safety

European regulators have already classified NAION as a very rare adverse effect of semaglutide

Semaglutide and tirzepatide represent new treatment modalities for type 2 diabetes mellitus (T2DM) and obesity, expanding the range of glucagon-like peptide-1 (GLP-1) receptor agonists

You start losing weight almost immediately after taking Mounjaro, but it can take up to 4 weeks for the medication to reach its steady state.

GLP-1 medications are transforming the way we approach weight lossbut theyre not a magic fix or a one-size-fits-all solution

The Global GLP-1 Receptor Agonists Obesity Drugs Market was valued at USD 9.96 Billion in 2024 and is expected to reach USD 33.12 Billion by 2032, growing at a CAGR of 16.20% (2025-2032).